Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

ClinicalTrials.gov ID: NCT06045221

Public ClinicalTrials.gov record NCT06045221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Oral Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.

Study identification

NCT ID
NCT06045221
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,698 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2023 (Actual)
Primary completion
Aug 22, 2025 (Actual)
Completion
Aug 22, 2025 (Actual)
Last update posted
Sep 15, 2026

2023 – 2025

United States locations

U.S. sites
64
U.S. states
28
U.S. cities
61
Facility City State ZIP Site status
Absolute Clinical Research Phoenix Arizona 85051 —
San Fernando Valley Health Institute Canoga Park California 91304 —
Neighborhood Healthcare Institute of Health Escondido California 92025 —
Velocity Clinical Research, Gardena Gardena California 90247 —
Biopharma Informatic, LLC Los Angeles California 90035 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Infinity Clinical Research - Norco Norco California 92860 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Norcal Endocrinology & Internal Medicine San Ramon California 94583 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
New West Physicians Clinical Research Golden Colorado 80401 —
Connecticut Clinical Research - Cromwell Cromwell Connecticut 06416 —
Clinical Research of West Florida, Inc. (Clearwater) Clearwater Florida 33765 —
South Florida Clinical Research Institute Margate Florida 33063 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
West Orange Endocrinology Ocoee Florida 34761 —
Latin Clinical Trial Center Florida Tamarac Florida 33321 —
Clinical Research of West Florida Tampa Florida 33606 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Balanced Life Health Care Solutions/SKYCRNG Lawrenceville Georgia 30046 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
North Georgia Clinical Research Woodstock Georgia 30189 —
Northwest Clinical Trials Boise Idaho 83704 —
Family First Medical Center Idaho Falls Idaho 83404 —
American Health Network of Indiana, LLC - Greenfield Greenfield Indiana 46140 —
Velocity Clinical Research, Valparaiso Valparaiso Indiana 46383 —
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 —
Tekton Research, Inc Wichita Kansas 67218 —
DelRicht Research New Orleans Louisiana 70115 —
Joslin Diabetes Center Boston Massachusetts 02215 —
Revival Research Institute, LLC Dearborn Michigan 48126 —
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157 —
Kansas City Research Institute Kansas City Missouri 64131 —
Logan Health Research Kalispell Montana 59901 —
Wr-Crcn, Llc Las Vegas Nevada 89106 —
Premier Research Trenton New Jersey 08611 —
Albany Medical College, Division of Community Endocrinology Albany New York 12203 —
Ellipsis Research Group - Brooklyn - 7th Street Brooklyn New York 11215 —
Great Lakes Medical Research, LLC Westfield New York 14787 —
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408 —
Lucas Research, Inc Morehead City North Carolina 28557 —
Accellacare - Piedmont Statesville North Carolina 28625 —
Wake Forest University Baptist Medical Center (WFUBMC) Winston-Salem North Carolina 27104 —
Aventiv Research Inc Columbus Ohio 43213 —
Tekton Research, Inc Moore Oklahoma 73160 —
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069 —
The Corvallis Clinic, P.C. Corvallis Oregon 97330 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18) Pittsburgh Pennsylvania 15236 —
The Research Center of The Upstate Greenville South Carolina 29607 —
New Phase Research and Development Knoxville Tennessee 37909 —
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119 —
Velocity Clinical Research, Austin Austin Texas 78759 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
Diabetes and Thyroid Center of Ft. Worth Fort Worth Texas 76132 —
Juno Research Houston Texas 77040 —
Endocrine Ips, Pllc Houston Texas 77079 —
Clear Brook Medical Associates Houston Texas 77089 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Valley Clinical Research Weslaco Texas 78596 —
Synexus Clinical Research US, Inc. Salt Lake City Utah 84106 —
Eastside Research Associates Redmond Washington 98052 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06045221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06045221 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →